The total net revenue for the year ended December 31, 2024 of approximately $11.7 million for prescription and non-prescription products, including license revenue, increased approximately 20% versus ...

Q4 2024 Management View CEO Lisa Conte reported a 20% growth in net revenue for 2024, reaching $11.7 million compared to $9.8 million in 2023. Q4 2024 revenue was $3.5 million, marking a 13% increase ...

With this acquisition, Tata AutoComp Systems Ltd (TACO) has consolidated its position as one of India's largest automotive ...

"As a cancer patient, having options to manage the side effects of life saving drugs is very important. I believe the published results of crofelemer for the prophylaxis of CTD are very exciting and ...

Okay, let’s preempt this missive with an important point: we like the Jaguar F-Pace SVR very much. To call it ‘old-school’ ...

"A brand refresh and a rebrand serve very different purposes, and understanding that distinction is key," Ljubica Jovanova, ...

Part of the risk Jaguar is undertaking is the admittedly fun, loud color options cryptically hinted at on the site. The Type ...

The authors include Pravin Chaturvedi, PhD, who is Jaguar's Chief Scientific Officer and Chair of Napo's Scientific Advisory Board, as well as leading oncologists and cancer patient advocates.